These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12089508)

  • 1. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.
    Matthias LJ; Yam PT; Jiang XM; Vandegraaff N; Li P; Poumbourios P; Donoghue N; Hogg PJ
    Nat Immunol; 2002 Aug; 3(8):727-32. PubMed ID: 12089508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide bond switches.
    Finkel E
    Nat Biotechnol; 2002 Sep; 20(9):887. PubMed ID: 12205507
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence of closely spaced protein thiols on the surface of mammalian cells.
    Donoghue N; Yam PT; Jiang XM; Hogg PJ
    Protein Sci; 2000 Dec; 9(12):2436-45. PubMed ID: 11206065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4 Metastability Is a Function of the Allosteric Disulfide Bond in Domain 2.
    Owen GR; Channell JA; Forsyth VT; Haertlein M; Mitchell EP; Capovilla A; Papathanasopoulos M; Cerutti NM
    Biochemistry; 2016 Apr; 55(15):2227-37. PubMed ID: 27009680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the DeltapKa between the active site cysteines of thioredoxin and DsbA.
    Carvalho AT; Fernandes PA; Ramos MJ
    J Comput Chem; 2006 Jun; 27(8):966-75. PubMed ID: 16586531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biotinylated phenylarsonous acids as bifunctional reagents for spatially close thiols: studies on reduced antibodies and the agonist binding site of reduced Torpedo nicotinic receptors.
    Moaddel R; Sharma A; Huseni T; Jones GS; Hanson RN; Loring RH
    Bioconjug Chem; 1999; 10(4):629-37. PubMed ID: 10411461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects.
    Sahaf B; Heydari K; Herzenberg LA; Herzenberg LA
    Arch Biochem Biophys; 2005 Feb; 434(1):26-32. PubMed ID: 15629105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
    Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control.
    Owen GR; Le D; Stoychev S; Cerutti NM; Papathanasopoulos M
    Biochem Biophys Res Commun; 2018 Mar; 497(2):811-817. PubMed ID: 29470989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry.
    Moolla N; Killick M; Papathanasopoulos M; Capovilla A
    Biochim Biophys Acta; 2016 Sep; 1860(9):1854-63. PubMed ID: 27233453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between disruption of CD4 receptor dimerization and increased human immunodeficiency virus type 1 entry.
    Bourgeois R; Mercier J; Paquette-Brooks I; Cohen EA
    Retrovirology; 2006 Jun; 3():31. PubMed ID: 16762062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox control on the cell surface: implications for HIV-1 entry.
    Matthias LJ; Hogg PJ
    Antioxid Redox Signal; 2003 Feb; 5(1):133-8. PubMed ID: 12626125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
    Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein minimization of the gp120 binding region of human CD4.
    Sharma D; Balamurali MM; Chakraborty K; Kumaran S; Jeganathan S; Rashid U; Ingallinella P; Varadarajan R
    Biochemistry; 2005 Dec; 44(49):16192-202. PubMed ID: 16331979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 neutralization by chimeric CD4-CG10 polypeptides fused to human IgG1.
    Meyuhas R; Noy H; Montefiori DC; Denisova G; Gershoni JM; Gross G
    Mol Immunol; 2005 May; 42(9):1099-109. PubMed ID: 15829299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 infection: is it time to reconsider our concepts?
    Krambovitis E; Spandidos DA
    Int J Mol Med; 2006 Jul; 18(1):3-8. PubMed ID: 16786149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridoxal 5'-phosphate as a novel weapon against autoimmunity and transplant rejection.
    Namazi MR
    FASEB J; 2003 Dec; 17(15):2184-6. PubMed ID: 14656979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.